Hill's most recent trade in Brookline Bancorp, Inc. was a trade of 31,729 Common done . Disclosure was reported to the exchange on Sept. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Brookline Bancorp Inc | Willard I. Hill | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Sep 2025 | 31,729 | 0 (0%) | 0% | - | Common | |
| Brookline Bancorp Inc | Willard I. Hill | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Sep 2025 | 731 | 0 (0%) | 0% | - | Common | |
| Stock Yards Bancorp Inc | James A. Hillebrand | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2025 | 7,571 | 0 | - | - | Stock Appreciation Right | |
| Stock Yards Bancorp Inc | James A. Hillebrand | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.00 per share. | 26 Aug 2025 | 7,571 | 114,863 (0%) | 0% | 40 | 302,840 | Common Stock |
| Stock Yards Bancorp Inc | James A. Hillebrand | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.90 per share. | 26 Aug 2025 | 5,409 | 109,454 (0%) | 0% | 82.9 | 448,406 | Common Stock |
| Stock Yards Bancorp Inc | James A. Hillebrand | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 83.32 per share. | 26 Aug 2025 | 2,162 | 107,292 (0%) | 0% | 83.3 | 180,138 | Common Stock |
| Adtalem Global Education Inc | Sara Hill | CHRO | Grant, award, or other acquisition of securities at price $ 134.88 per share. | 23 Aug 2025 | 2,226 | 10,916 (0%) | 0% | 134.9 | 300,243 | Common Stock |
| Adtalem Global Education Inc | Sara Hill | CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 134.88 per share. | 23 Aug 2025 | 1,003 | 9,913 (0%) | 0% | 134.9 | 135,285 | Common Stock |
| Parke Bancorp Inc | Jonathan D. Hill | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.03 per share. | 22 Aug 2025 | 2,000 | 10,000 (0%) | 0% | 19.0 | 38,060 | Common Stock |
| Parke Bancorp Inc | Jonathan D. Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.09 per share. | 22 Aug 2025 | 2,000 | 8,000 (0%) | 0% | 22.1 | 44,180 | Common Stock |
| Amrize Ltd. - Registered S... | Jaime Hill | President, Building Materials | Purchase of securities on an exchange or from another person at price $ 49.59 per share. | 22 Aug 2025 | 500 | 14,101 | - | 49.6 | 24,793 | Ordinary Shares |
| Lyell Immunopharma Inc | Stephen Hill | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2025 | 8,000 | 16,849 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Stephen Hill | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.54 per share. | 20 Aug 2025 | 1,004 | 15,845 | - | 10.5 | 10,586 | Common Stock |
| Addus HomeCare Corporation | Veronica Hill-Milbourne | Director | Sale of securities on an exchange or to another person at price $ 114.93 per share. | 19 Aug 2025 | 1,571 | 5,067 (0%) | 0% | 114.9 | 180,555 | Common Stock |
| Replimune Group Inc | Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.37 per share. | 15 Aug 2025 | 9,154 | 134,368 (0%) | 0% | 5.4 | 49,157 | Common Stock |
| Amrize Ltd. - Registered S... | Jaime Hill | President, Building Materials | Purchase of securities on an exchange or from another person at price $ 52.00 per share. | 15 Aug 2025 | 4,000 | 13,601 | - | 52.0 | 207,980 | Ordinary Shares |
| National Cinemedia Inc | Juliana F. Hill | Director | Sale of securities on an exchange or to another person at price $ 4.44 per share. | 14 Aug 2025 | 13,372 | 40,365 (0%) | 0% | 4.4 | 59,401 | Common Stock |
| Intuit Inc | Caryl Lyn Hilliard | EVP, People and Places | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 111 | 20,567 (0%) | 0% | 0 | Common Stock | |
| Intuit Inc | Caryl Lyn Hilliard | EVP, People and Places | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 111 | 0 | - | - | Restricted Stock Units (MSPP Purchased Award) | |
| Intuit Inc | Caryl Lyn Hilliard | EVP, People and Places | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 106 | 0 | - | - | Restricted Stock Units (MSPP Matching Award) | |
| Intuit Inc | Caryl Lyn Hilliard | EVP, People and Places | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 106 | 20,673 (0%) | 0% | 0 | Common Stock | |
| Intuit Inc | Caryl Lyn Hilliard | EVP, People and Places | Payment of exercise price or tax liability using portion of securities received from the company at price $ 709.74 per share. | 12 Aug 2025 | 104 | 20,569 (0%) | 0% | 709.7 | 73,813 | Common Stock |
| Lyell Immunopharma Inc | Stephen Hill | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.34 per share. | 11 Aug 2025 | 94 | 8,849 | - | 10.3 | 972 | Common Stock |
| Lyell Immunopharma Inc | Stephen Hill | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 10.53 per share. | 11 Aug 2025 | 91 | 8,943 | - | 10.5 | 958 | Common Stock |
| Celanese Corp Ordinary Shares | Kathryn M. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2025 | 1 | 2,946 | - | - | Phantom Stock | |
| Amrize Ltd. - Registered S... | Jaime Hill | President, Building Materials | Purchase of securities on an exchange or from another person at price $ 46.40 per share. | 08 Aug 2025 | 4,000 | 9,601 | - | 46.4 | 185,600 | Ordinary Shares |
| eXp World Holdings Inc | Jesse Hill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2025 | 124,780 | 124,780 | - | - | Stock Options (Right to buy) | |
| eXp World Holdings Inc | Jesse Hill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2025 | 22,531 | 38,011 | - | - | Restricted Stock Unit | |
| Five Below Inc | George S. Hill | Chief Retail Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 133.16 per share. | 01 Aug 2025 | 1,355 | 41,317 (0%) | 0% | 133.2 | 180,432 | Common Stock |
| GATX Corp | Kevin J. Hillesland | SVP, Structured Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2025 | 2,200 | 0 | - | - | 2019 NQ Stock Option (Right to Buy) | |
| GATX Corp | Kevin J. Hillesland | SVP, Structured Finance | Sale of securities on an exchange or to another person at price $ 152.59 per share. | 31 Jul 2025 | 2,200 | 7,606 (0%) | 0% | 152.6 | 335,688 | Common Stock |
| GATX Corp | Kevin J. Hillesland | SVP, Structured Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.52 per share. | 31 Jul 2025 | 2,200 | 9,806 (0%) | 0% | 71.5 | 157,355 | Common Stock |
| Hess Corporation | Gregory P. Hill | COO and President, E&P | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2025 | 142,594 | 0 (0%) | 0% | - | Common Stock, $1.00 par value | |
| Hess Corporation | Gregory P. Hill | COO and President, E&P | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2025 | 23,826 | 0 | - | - | 2023 Performance Share Unit | |
| Hess Corporation | Gregory P. Hill | COO and President, E&P | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2025 | 10,293 | 0 | - | - | Option to purchase Common Stock | |
| Hess Corporation | Gregory P. Hill | COO and President, E&P | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2025 | 10,293 | 0 | - | - | Option to purchase Common Stock | |
| Hess Corporation | Gregory P. Hill | COO and President, E&P | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2025 | 10,292 | 0 | - | - | Option to purchase Common Stock | |
| Hess Corporation | Gregory P. Hill | COO and President, E&P | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2025 | 7,460 | 0 | - | - | Option to purchase Common Stock | |
| Hess Corporation | Gregory P. Hill | COO and President, E&P | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2025 | 7,460 | 0 | - | - | Option to purchase Common Stock | |
| Hess Corporation | Gregory P. Hill | COO and President, E&P | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2025 | 7,460 | 0 | - | - | Option to purchase Common Stock | |
| Hess Corporation | Gregory P. Hill | COO and President, E&P | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2025 | 9 | 0 | - | - | Option to purchase Common Stock | |
| Five Below Inc | George S. Hill | Chief Retail Officer | Sale of securities on an exchange or to another person at price $ 140.00 per share. | 17 Jul 2025 | 1,500 | 42,672 (0%) | 0% | 140 | 210,000 | Common Stock |
| Five Below Inc | George S. Hill | Chief Retail Officer | Other type of transaction at price $ 118.07 per share. | 17 Jul 2025 | 42 | 44,172 (0%) | 0% | 118.1 | 4,959 | Common Stock |
| Omada Health Inc. | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2025 | 376 | 10,112 | - | 0 | Common Stock | |
| Telos Corp | Donna K. Hill | VP, Human Resources | Grant, award, or other acquisition of securities at price $ 3.12 per share. | 01 Jul 2025 | 3,036 | 56,823 | - | 3.1 | 9,472 | Common Stock |
| Telos Corp | Donna K. Hill | VP, Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.12 per share. | 01 Jul 2025 | 1,075 | 55,748 | - | 3.1 | 3,354 | Common Stock |
| Clearwater Paper Corp | Jeanne Hillman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 847 | 7,365 | - | - | Phantom Stock Units | |
| Sonoco Products Co | Robert R. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 792 | 25,005 | - | - | Phantom Stock Units | |
| Clearfield Inc | John P. Hill | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 26.35 per share. | 30 Jun 2025 | 498 | 152,744 (1%) | 0% | 26.3 | 13,122 | Common Stock (ESPP) |
| Hillenbrand Inc | Daniel C. Hillenbrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 48 | 4,364 | - | - | Restricted Stock Units (Deferred Stock Award 2/13/20) | |
| Hillenbrand Inc | Daniel C. Hillenbrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 45 | 4,088 | - | - | Restricted Stock Units (Deferred Stock Award 2/18/25) | |
| Hillenbrand Inc | Daniel C. Hillenbrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 34 | 3,074 | - | - | Restricted Stock Units (Deferred Stock Award 2/11/21) | |
| Hillenbrand Inc | Daniel C. Hillenbrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 34 | 3,139 | - | - | Restricted Stock Units (Deferred Stock Award 2/20/24) | |
| Hillenbrand Inc | Daniel C. Hillenbrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 32 | 2,918 | - | - | Restricted Stock Units (Deferred Stock Award 2/14/19) | |
| Hillenbrand Inc | Daniel C. Hillenbrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 32 | 2,889 | - | - | Restricted Stock Units (Deferred Stock Award 2/24/23) | |
| Hillenbrand Inc | Daniel C. Hillenbrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 31 | 2,839 | - | - | Restricted Stock Units (Deferred Stock Award 2/10/22) | |
| Hillenbrand Inc | Daniel C. Hillenbrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 12 | 1,102 | - | - | Restricted Stock Units (Deferred Stock Award 5/10/18) | |
| Fulcrum Therapeutics Inc | Colin Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 36,000 | 36,000 | - | - | Stock Option (right to buy) | |
| Campbell Soup Co | Grant H. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 2,309 | 26,133 (0%) | 0% | 0 | Common Stock | |
| HilleVax Inc | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2025 | 17,199 | 59,224 | - | 0 | Common Stock | |
| Amrize Ltd. - Registered S... | Jaime Hill | President, Building Materials | Other type of transaction at price $ 0.00 per share. | 23 Jun 2025 | 5,601 | 5,601 | - | 0 | Ordinary Shares | |
| Addus HomeCare Corporation | Veronica Hill-Milbourne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 1,172 | 6,638 (0%) | 0% | 0 | Common Stock | |
| Upland Software Inc | Michael D. Hill | CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.84 per share. | 16 Jun 2025 | 11,152 | 351,230 (1%) | 0% | 1.8 | 20,520 | Common Stock |
| eXp World Holdings Inc | Jesse Hill | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2025 | 1,161 | 1,161 (0%) | 0% | 0 | Common Stock | |
| eXp World Holdings Inc | Jesse Hill | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.06 per share. | 14 Jun 2025 | 394 | 767 (0%) | 0% | 9.1 | 3,570 | Common Stock |
| Sangamo Therapeutics Inc | Kenneth J. Hillan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | Kenneth J. Hillan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 25,000 | 99,600 (0%) | 0% | 0 | Common Stock | |
| Eagle Financial Services, ... | Edward Hill | Director | Purchase of securities on an exchange or from another person at price $ 29.93 per share. | 12 Jun 2025 | 1,000 | 3,900 | - | 29.9 | 29,933 | Common Stock, $2.50 Par Value |
| Telos Corp | Donna K. Hill | VP, Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 76,075 | 76,075 | - | - | Performance-Based RSUs | |
| Yext Inc | Hillary B. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2025 | 31,250 | 106,718 (0%) | 0% | - | Common Stock | |
| Yext Inc | Hillary B. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2025 | 31,250 | 0 | - | - | Restricted Stock Unit | |
| Yext Inc | Hillary B. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 27,131 | 27,131 | - | - | Restricted Stock Unit | |
| CS Disco Inc | Scott Anthony Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 34,169 | 223,230 | - | 0 | Common Stock | |
| Sonoco Products Co | Robert R. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 275 | 24,213 | - | - | Phantom Stock Units | |
| Relay Therapeutics Inc | Linda A. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 136,681 | 136,681 | - | - | Stock Option (Right to Buy) | |
| Omega Healthcare Investors Inc | Barbara B. Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2025 | 7,472 | 0 | - | - | Profits Interest Units | |
| Omega Healthcare Investors Inc | Barbara B. Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2025 | 7,472 | 41,994 | - | - | OP Units | |
| Omega Healthcare Investors Inc | Barbara B. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 7,079 | 7,079 | - | - | Profits Interest Units | |
| Omada Health Inc. | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 9,736 | 9,736 | - | 0 | Common Stock | |
| SI-BONE Inc | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 8,675 | 32,815 (0%) | 0% | 0 | Common Stock | |
| Five Below Inc | George S. Hill | Chief Retail Officer | Sale of securities on an exchange or to another person at price $ 131.90 per share. | 05 Jun 2025 | 3,000 | 45,630 (0%) | 0% | 131.9 | 395,700 | Common Stock |
| Five Below Inc | George S. Hill | Chief Retail Officer | Sale of securities on an exchange or to another person at price $ 135.00 per share. | 05 Jun 2025 | 1,500 | 44,130 (0%) | 0% | 135 | 202,500 | Common Stock |
| NovoCure Ltd | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 16,697 | 16,697 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 11,215 | 16,806 (0%) | 0% | 0 | Ordinary Shares | |
| CVRx Inc | Mitchell C. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,554 | 19,554 | - | - | Stock Option (right to buy) | |
| Fold Holdings inc. - Ordin... | Kirstin Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 12,500 | 12,500 | - | 0 | Common Stock | |
| NovoCure Ltd | Jeryl L. Hilleman | Director | Sale of securities on an exchange or to another person at price $ 17.26 per share. | 03 Jun 2025 | 999 | 5,591 (0%) | 0% | 17.3 | 17,247 | Ordinary Shares |
| Alkami Technology Inc | William B. Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 28.36 per share. | 02 Jun 2025 | 20,365 | 430,255 | - | 28.4 | 577,551 | Common Stock |
| Western Asset High Income | Hillary A. Sale | Director | Purchase of securities on an exchange or from another person at price $ 3.88 per share. | 02 Jun 2025 | 5,167 | 5,167 (0%) | 0% | 3.9 | 20,058 | Common Stock |
| Western Asset Mortgage | Hillary A. Sale | Director | Purchase of securities on an exchange or from another person at price $ 11.80 per share. | 02 Jun 2025 | 1,694 | 1,694 (0%) | 0% | 11.8 | 19,981 | Common Stock |
| Avalonbay Communities Inc | Stephen P. Hills | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 971 | 8,780 (0%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Cardlytics Inc | Scott Anthony Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2025 | 11,000 | 57,748 (0%) | 0% | 0 | Common Stock | |
| Cardlytics Inc | Scott Anthony Hill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2025 | 11,000 | 0 | - | - | Restricted Stock Unit | |
| Distribution Solutions Group | Lee S. Hillman | Director | Grant, award, or other acquisition of securities at price $ 27.00 per share. | 22 May 2025 | 4,630 | 107,261 | - | 27 | 125,010 | Common Stock - Restricted Stock Units |
| Knife River Corp | Thomas W. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 1,551 | 3,456 | - | 0 | Common Stock | |
| Evoke Pharma Inc | Malcolm R. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 1,218 | 8,269 | - | - | Stock Option (Right to Buy) | |
| Cardlytics Inc | Scott Anthony Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 11,000 | 11,000 | - | - | Restricted Stock Units | |
| Replimune Group Inc | Emily Hill | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.05 per share. | 20 May 2025 | 2,535 | 143,522 (0%) | 0% | 8.1 | 20,407 | Common Stock |
| Vulcan Materials Co | J. Thomas Hill | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 276.02 per share. | 19 May 2025 | 35,978 | 0 (0%) | 0% | 276.0 | 9,930,555 | Common Stock (401k) |
| Vulcan Materials Co | J. Thomas Hill | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 121.69 per share. | 19 May 2025 | 27,200 | 70,362 (0%) | 0% | 121.7 | 3,309,968 | Common Stock |
| Vulcan Materials Co | J. Thomas Hill | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2025 | 27,200 | 0 | - | - | Stock Appreciation Right |